Cooper Companies, Inc. (The) (COO) Given Buy Rating at BMO Capital Markets

BMO Capital Markets reissued their buy rating on shares of Cooper Companies, Inc. (The) (NYSE:COO) in a research note issued to investors on Friday morning. The firm currently has a $272.00 target price on the medical device company’s stock.

A number of other equities research analysts have also recently weighed in on the stock. Jefferies Group LLC reiterated a buy rating and issued a $250.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Zacks Investment Research cut shares of Cooper Companies, Inc. (The) from a buy rating to a hold rating in a research report on Thursday, June 22nd. Stifel Nicolaus boosted their price target on shares of Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a buy rating in a research report on Friday, June 2nd. Piper Jaffray Companies boosted their price target on shares of Cooper Companies, Inc. (The) to $265.00 and gave the stock an overweight rating in a research report on Wednesday, July 19th. Finally, KeyCorp reiterated a sector weight rating on shares of Cooper Companies, Inc. (The) in a research report on Friday, July 21st. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $245.89.

Cooper Companies, Inc. (NYSE:COO) traded down 5.84% during mid-day trading on Friday, reaching $236.18. 1,026,728 shares of the company were exchanged. The company has a 50 day moving average of $246.43 and a 200-day moving average of $221.27. The company has a market capitalization of $11.54 billion, a price-to-earnings ratio of 35.41 and a beta of 0.59. Cooper Companies, Inc. has a 1-year low of $158.73 and a 1-year high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.39%. The business had revenue of $556 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same period in the previous year, the business earned $2.30 earnings per share. The company’s revenue was up 8.0% on a year-over-year basis. On average, equities research analysts forecast that Cooper Companies, Inc. will post $9.64 EPS for the current year.

WARNING: “Cooper Companies, Inc. (The) (COO) Given Buy Rating at BMO Capital Markets” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://stocknewstimes.com/2017/09/02/cooper-companies-inc-the-coo-given-buy-rating-at-bmo-capital-markets.html.

The company also recently declared a semiannual dividend, which was paid on Monday, August 7th. Investors of record on Friday, July 21st were paid a $0.03 dividend. The ex-dividend date of this dividend was Wednesday, July 19th. This represents a dividend yield of 0.02%. Cooper Companies, Inc. (The)’s payout ratio is 0.86%.

In related news, Director Stanley Md Zinberg sold 816 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $243.14, for a total value of $198,402.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Carol R. Kaufman sold 44,092 shares of the business’s stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $242.81, for a total value of $10,705,978.52. Following the completion of the sale, the executive vice president now owns 60,419 shares of the company’s stock, valued at $14,670,337.39. The disclosure for this sale can be found here. In the last three months, insiders sold 67,331 shares of company stock valued at $16,400,454. 1.60% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Advisory Services Network LLC raised its position in shares of Cooper Companies, Inc. (The) by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after buying an additional 107 shares during the period. YorkBridge Wealth Partners LLC raised its position in shares of Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock worth $105,000 after buying an additional 81 shares during the period. Acrospire Investment Management LLC raised its position in shares of Cooper Companies, Inc. (The) by 50.0% in the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after buying an additional 200 shares during the period. Archford Capital Strategies LLC raised its position in shares of Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock worth $135,000 after buying an additional 363 shares during the period. Finally, Penserra Capital Management LLC raised its position in shares of Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock worth $156,000 after buying an additional 68 shares during the period. Institutional investors own 96.09% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)




Receive News & Ratings for Cooper Companies Inc. (The) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

17 − 6 =